OA03.02 Nationwide Comparative Study of PD-L1 IHC Assays on Lung Cancer: Initial Report of LC-SCRUM-IBIS Project

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.246
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Design of PD-L1 Inhibitors for Lung Cancer

Bioinformation
2019English

OA11.04 a Comparative Study of PD-L1 Immunohistochemical Assays With Four Reliable Antibodies in Thymic Carcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.01-18 Comparison of PD-L1 Immunohistochemical Assays and Clinical Response to Anti PD-1 Checkpoint Inhibitors in Patients With Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Aspirin‐targeted PD‐L1 in Lung Cancer Growth Inhibition

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2020English

PD-L1 Gene Expression in Japanese Lung Cancer Patients

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2012English

Interchangeability of PD-L1 Laboratory-Developed Test by 22C3 Antibody Concentrate Among Ihc Platforms in Gastric Cancer

Pathology
Forensic MedicinePathology
2020English

Progress in the Study on PD-L1 Inhibitor in the Treatment of EGFR-Mutant Non-Small Cell Lung Cancer

Clinical Oncology and Research
2020English

6P Expression of PD-L1 in Lung Cancer Cells Regulates Treg Cell Differentiation

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

PD-1 and PD-L1 Expression in Molecularly Selected Non-Small-Cell Lung Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy